Multidrug efflux pumps of bacteria are involved in the resistance to various antibiotics and toxic compounds. In Rhizobium etli, a mutualistic symbiont of Phaseolus vulgaris (bean), genes resembling multidrug efflux pump genes were identified and designated rmrA and rmrB. rmrA was obtained after the screening of transposongenerated fusions that are inducible by bean-root released flavonoids. The predicted gene products of rmrAB shared significant homology to membrane fusion and major facilitator proteins, respectively. Mutants of rmrA formed on average 40% less nodules in bean, while mutants of rmrA and rmrB had enhanced sensitivity to phytoalexins, flavonoids, and salicylic acid, compared with the wild-type strain. Multidrug resistance genes emrAB from Escherichia coli complemented an rmrA mutant from R. etli for resistance to high concentrations of naringenin.
Rhizobia form nitrogen-fixing nodules on the roots of legumes. Nodule formation is a complex process that is initiated with the release of flavonoids by the legume root and these compounds induce the expression of Rhizobium spp. symbiotic genes (Hanin et al. 1999; Perret et al. 1999 ). In the interaction with symbionts, such as mycorrhizae (Hirsch and Kapulnik 1998) and rhizobia (Baron and Zambryski 1995; Spaink 1995) , some of the plant defense responses are triggered. For example, legumes produce phytoalexins in response to various biological, chemical, or physical stresses (Kuc 1995) as well as to the presence of rhizobia (Dakora et al. 1993; Schmidt et al. 1994; Wolff and Werner 1990) . These bacteria can survive antibacterial concentrations of phytoalexins either by acquired resistance (Parniske et al. 1991) or by their ability to catabolize these compounds (Rao and Cooper 1994) .
In Phaseolus vulgaris (bean), flavonoid phytoalexins such as phaseollin, phaseollinisoflavan, phaseollidin, kievitone, and coumestrol increase upon wounding, by abiotic stresses, and also in response to viruses or pathogenic rhizobacteria (Dixon 1986 ). R. etli exopolysaccharide (EPS -) or lipopolysaccharide (LPS -) mutants display enhanced sensitivity to coumestrol and other coumestans from bean roots, indicating that EPS and LPS may act as barriers to restrain the entry of root inhibitory compounds into Rhizobium etli cells (Eisenschenk et al. 1994) . In addition, R. etli EPS and LPS have been implicated in actively suppressing the plant defense response (Niehaus et al. 1993 ). Salicylic acid is another phenolic compound that has been implicated in plant defense against pathogens (Klessig and Malamy 1994) . R. meliloti nodulation factors have been reported to inhibit the salicylic acid-mediated defense response in alfalfa (Martínez-Abarca et al. 1998) .
The main P. vulgaris nodule isolates in Mesoamerica are R. etli strains (Segovia et al. 1993) . Here, we describe the identification in R. etli of genes resembling the multidrug resistance (MDR) loci from microbial pathogens and present their structural and functional characterization. We also propose a role for the rmrAB (Rhizobium multiresistance) gene products in phytoalexin and salicylic acid resistance in R. etli.
R. etli CFN42 derivatives carrying Tn5-B30 (Simon et al. 1989 ) with a promoterless nptII reporter gene were obtained by mating Escherichia coli S17-1 (Simon et al. 1983 ) containing pSUP102::Tn5-B30 with strain CFN42 (Table 1) . The R. etli CFN42 mutants were tested for growth in modified PY media (0.25% peptone, 0.15% yeast extract, and 7 mM CaCl 2 ) containing different kanamycin concentrations in the presence or absence of root exudates (obtained as described by Rosenblueth et al. 1998) or with naringenin (1.2 µM). Naringenin, genistein, and other flavonoids are inducers of R. etli nodulation genes and have been found in bean exudates (Hungria et al. 1991) . Bacteria that grew in the presence of bean root exudates or naringenin but not in their absence were considered to be mutated on genes up-regulated by root exudates or flavonoids. A mutant, CFNEA31, whose growth on kanamycin (100 µg ml -1 ) was dependent on naringenin (1.2 µM) but also on genistein (0.4 µM), quercetagetin (1.0 µM), or chrysin (1.0 µM), was selected for further analysis. The flavonoiddependent growth of CFNEA31 was also estimated in liquid MM containing kanamycin by measuring cell densities at OD 600 . The MM had the following composition (per liter of demineralized water): sucrose, 2 g; K 2 HPO 4 , 0.17 g; MgSO 4 , 0.25 g; KNO 3 , 0.01 g; KH 2 PO 4 , 1.0 g; NaCl, 0.16 g; Fe citrate, 1.2 g; CaCl 2 , 1.2 g; biotin, 10 µg; and trace minerals (Fahraeus 1957) . In two separate experiments, we found significantly higher growth in kanamycin in the presence of genistein (5 µM) than in its absence (P < 0.01; Fig. 1 ). Cell growth studies also included cultures of strain CFNEA31 grown in the absence of kanamycin. The addition of genistein up to 5 µM did not affect growth of the wild-type strain CFN42 in MM.
The location of the Tn5-B30 insertion in the CFNEA31 genome was determined with the plasmid-cured CFN42 derivatives CFNX182 and CFNX183 (Brom et al. 1992) . In a Southern blot hybridization, the flanking sequences of the insert (cloned in pUC18) hybridized to CFNX182 but not to CFNX183 (cured of plasmid b). Hybridization was also obtained to cosmid pCOS126 (Cava et al. 1989 ) from CFN42 plasmid b (which carries LPS genes; Sambrook et al. 1989) and localized to two EcoRI fragments of 1.3 and 5.6 kb ( Fig.  2A ), which were subsequently cloned and used for sequencing. The 1.3-kb DNA fragment and a 3.7-kb fragment from the 5′ end of the 5.6-kb subclone were sequenced by primer walking with a 373A automated DNA sequencer and Taq DyeDeoxy Terminator Cycle Sequencing kits (Applied Biosystems, Foster City, CA). The flanking regions of Tn5-B30 obtained from CFNEA31 were sequenced and their alignment with the wild-type sequence derived from pCOS126 subclones allowed us to determine that the Tn5-B30 in CFNEA31 was inserted 299 bp downstream of the start codon of an open reading frame (ORF1) of 1,191 bp. ORF1 is preceded by a potential ribosomal binding site (RBS) and encodes a predicted 41.8-kDa protein that was compared with protein sequences in the NCBI data bases with the BLAST program (Altschul et al. 1990 ) and pairwise alignments with GCG Gap (Henikoff and Henikoff 1992) to estimate the identity (I) and similarity (S) scores. Homology was observed over the entire length of the ORF1 putative protein with the EmrK (accession no. P52599) and EmrA (accession no. 27303) multiresistance proteins from E. coli (34.3% I, 53.5% S and 34.0% I, 52.1% S, respectively), the VceA protein from Vibrio cholerae (31.7% I, 50.0% S) (accession no. 2815577), and the EmrA protein from Haemophilus influenzae (29.8% I, 49.7% S) (accession no. P44928).
An ORF of 1,581 bp (ORF2) was found downstream of ORF1 ( Fig. 2A) in the same orientation. ORF2 was also preceded by a potential RBS and encoded a predicted 56.1-kDa protein with homology over their entire lengths to VceB from V. cholerae (29.3% I, 55.6% S) (accession no. 2815578), Selbitschka et al. 1993 a Gm, gentamicin; Nal, nalidixic acid; Sm, streptomycin; Tc, tetracycline; sac, levansucrase gene; r, resistant.
Fig. 1.
Growth dependence of CFNEA31 mutant on genistein in the presence of kanamycin. Growth of CFNEA31, carrying the nptII kanamycin resistance gene as a promoter probe from Tn5::B30, was screened by testing kanamycin (100 µg/ml) resistance with genistein 1 µM (n), 5 µM (v), or without genistein (). As a control, growth of CFNEA31 without kanamycin was measured (). Statistical significance of differences between treatments was determined with a t test (P < 0.01). Growth was measured by increase of OD 600 (optical density at 600 nm); values are means from three replicates ± standard errors represented by bars. EmrB from E. coli (28.2% I, 53.2% S) (accession no. 27304), EmrB from H. influenzae (26.3% I, 53.8% S) (accession no. P44927), and EmrY from E. coli (25.5% I, 53.4% S) (accession no. 52600). These proteins exhibited the greatest degree of sequence similarity in their N-terminal regions. This feature was found in previous analyses of MDR proteins (Marger and Saier 1993; Paulsen and Skurray 1993) and it was suggested that the conserved sequence may be involved in common functions, such as proton translocation, while specialized functions, such as substrate binding, are encoded by the C-terminal regions (Rouch et al. 1990 ). The drug extrusion consensus (GxhhGPxIGG, with "x" as any amino acid; and "h" as hydrophobic; upper case, high frequency of occurrence), a highly conserved motif of exporters of the major facilitator superfamily (Lewis 1994; Marger and Saier 1993; Paulsen and Skurray 1993) , was identified within the ORF2 protein sequence.
A nucleotide sequence similar to the E. coli and B. japonicum σ 70 (the major sigma factor used for normal growth conditions in E. coli) consensus binding sequence (Beck et al. 1997; Lisser and Margalit 1993) was identified upstream of ORF1. This sequence is identical to the -35 E. coli/B. japonicum region and five out of six nucleotides of the -10 site were conserved (Fig. 2B ). An additional feature of this region is a dyad symmetry at the 5′ end of ORF1, which may be a regulatory palindrome. Neither promoter sequence nor putative transcription terminator were found immediately upstream of ORF2 and the distance between the TAG translation stop codon of ORF1 and the ATG translation initiation codon of ORF2 is 24 bp, suggesting that the two genes could be organized into an operon. Moreover, a potential transcription terminator (AAGCCCTCCTTTATCCGGAAAGGAGGGCTT) was found downstream of ORF2. No nod box (Rostas et al. 1986 ) or A3-like sequence (Mao et al. 1994) was identified in 400 bp upstream of ORF1.
A hydrophobicity analysis was performed with the Gene Works package (release 2.4; IntelliGenetics, Mountain View, CA) (Kyte and Doolittle 1982) and Psort program (Nakai and Kanehisa 1991) to examine the predicted proteins for potential hydrophobic and hydrophilic regions. The ORF1 putative protein showed a hydrophobic domain at the amino terminal region, forming a single α-helix that spans the membrane (between amino acids 54 and 70) and a large, hydrophilic, Cterminal domain that could be located in the periplasm. This hydropathy pattern is conserved in EmrA (Lomovskaya and Lewis 1992 ) and in VceA (Colmer et al. 1998 ). In the case of the ORF2 putative protein, the analysis revealed 14 hydrophobic domains that may form transmembrane α-helical segments, which is a pattern also conserved in EmrB (Lomovskaya and Lewis 1992) and VceB (Colmer et al. 1998 ) (data not shown).
Based on the similarity in sequence, length, hydropathy plots, and proteins encoded by genes adjacent to EmrA and VceA, the protein encoded by ORF1 was included in the membrane fusion protein (MFP) family and designated RmrA (Rhizobium multiresistance gene A). The MFPs may cause fusion of the inner and outer membranes, as proposed by Saier et al. (1994) . Based on its similarity at the amino acid level with EmrB, the hydropathy profile, and the presence of the extrusion consensus sequence, the ORF2 putative protein may be included in the major facilitator superfamily , in particular, the drug-resistance protein family (Griffith et al. 1992; Marger and Saier 1993) , and was therefore named RmrB. This group of transporter proteins share a common structure and function. They are integral membrane proteins with 12 to 14 transmembrane segments and they confer drug efflux driven by proton motive force (Marger and Saier 1993) .
A third ORF of 357 bp, oriented in the opposite direction and named ORFR, was also identified 136 bp upstream of rmrA ( Fig. 2A) . Analysis of the protein sequence deduced from ORFR showed that it encodes a putative 13.0-kDa protein that is similar to members of the TetR-AcrR family (Hinrichs et al. 1994) . ORFR product contains a helix-turnhelix motif similar to that of proteins that exert transcriptional control. Upstream of ORFR, an RBS was localized, as well as a potential promoter (Fig. 2B ). This potential promoter overlaps the rmrA upstream sequence between the ATG start codon and putative promoter of rmrA. This organization is similar to that of the qacA gene (encoding an efflux transporter of quaternary ammonium antiseptics and some basic dyes in Staphylococcus aureus) and its putative regulator, ORF188 (Rouch et al. 1990 ). The protein encoded by ORFR could be involved in regulating rmrAB but this possibility remains to be tested.
With the sacRB-containing vector, pWS233, (Selbitschka et al. 1993 ) two additional mutants of R. etli CFN42 (CFNEA34 and CFNEA35) were obtained by mutagenesis of rmrA and rmrB genes, respectively (Table 1 ). The mutant strains (CFNEA31, CFNEA34, and CFNEA35) and the wild-type strain CFN42 had identical growth rates in PY medium (per liter: 5 g of peptone, 3 g of yeast extract, and 1 g of CaCl 2 ·H 2 0) and MM media (data not shown).
The bean-nodulating ability of strains CFNEA31, CFNEA31 (pLAFR1; see below for the details of genetic construction), and CFNEA34 was diminished, compared with the wild-type strain (P < 0.01) and was restored in CFNEA32, which contains the plasmid pCOS126 (Fig. 3) . In three independent experiments, rmrA mutants CFNEA31 and CFNEA34 produced an average of 40% less nodules, when compared with the wild-type strain. A smaller decrease in nodulation was observed with CFNEA35 (data not shown). The nodules were otherwise morphologically unaltered and fixed nitrogen. CFNEA31 produced Nod factors identical to those of the wild-type strain and its LPS profiles and motility were unaltered (data not shown).
To study the role of the RmrAB with regard to tolerance to toxic compounds we used different compounds at concentrations that may be toxic in MM plates and liquid MM. On plates with MM, CFNEA31 was unable to grow in the presence of 0.2 mM phaseollin and 0.1 mM phaseollidin while growth of CFN42 was obtained. In liquid MM, in experiments similar to those performed when determining minimal inhibitory concentration (Colmer et al. 1998) , there was no growth of strains CFNEA31, CFNEA34, and CFNEA35 in the presence of 735 µM naringenin, 1.2 mM coumaric acid, or 725 µM salicylic acid. In contrast, the wild-type strain grew even at higher concentrations of these compounds (1.1 mM naringenin, 1.8 mM coumaric acid, or 3.6 mM salicylic acid). The 4-kb EcoRI-HindIII fragment of pSE380emrAB (O. Lomovskaya, unpublished) containing emrAB from E. coli was cloned into pRK7813 (Jones and Gutterson 1987) , yielding pRKemrAB. The cosmids pLAFR1 and pCOS126 and the plasmids pRK7813 and pRKemrAB were transferred to CFNEA31 in matings from E. coli S17-1. Transconjugants were selected in PY medium supplemented with 10 µg ml -1 nalidixic acid and 25 µg ml -1 tetracycline. CFNEA31 complemented with pCOS126 (strain CFNEA32) or with pRKemrAB (strain CFNEA33) grew in the presence of 300 µg ml -1 naringenin, as did the wild-type controls, while the growth of CFNEA31 with either pLAFR1 or pRK7813 was completely inhibited. These complementations suggest a functional similarity between the products of the E. coli emrAB genes and of the rmrAB locus of R. etli CFN42.
The MDR system is found mostly in pathogens and to our knowledge has not been previously described in rhizobia. Agrobacterium tumefaciens, a pathogen related to rhizobia, forms tumors on a variety of dicotyledonous plants. This pathogen possesses an efflux pump inducible by alfalfa isoflavonoids that is required for competitive colonization of the bacteria of alfalfa roots (Palumbo et al. 1998) . Our findings support the notion discussed by Saier et al. (1998) that the MDR systems have not arisen recently as a result of extensive exposure of microorganisms to drugs and that they play important physiological roles in the extrusion of natural toxic substances. We propose that rmrAB encodes an inducible export system that prevents the accumulation of toxic plant compounds within the bacterial cell, thereby conferring an advantage to R. etli for bean nodulation. CFNEA32 (CFNEA31 complemented with pCOS126, ), CFNEA34 (•), and CFNEA31 (pLAFR1) (n) on beans. Seeds of Phaseolus vulgaris cv. Negro Jamapa or N-8-116 were surface sterilized. Two-day-old seedlings were transfered to 250-ml Erlenmeyer flasks containing agar or vermiculite with nitrogen-free Fahraeus medium (Fahraeus 1957) . One hundred microliters with around 10 6 cells of each bacterial suspension was used per plant as inoculum. Mean number of nodules from five plants was determined at 10, 15, or 20 days post inoculation. Statistical significance of differences between treatments was determined with a t test (P < 0.01). Bars represent standard errors. Two independent plants assays were performed; data for one experiment are presented.
